Lithium Recovery
Product
Application
Contact Us
Sunresin Park,No.135, jinye Road, Xi’an Hi-tech Industrial Development Zone, Shaanxi-710076, China
seplite@sunresin.com
seplite_europe@sunresin.com
+86-29-89182091
Lithium Recovery
High-purity Lithium Carbonate Production Technique
Because of its low lithium content and high magnesium content,lithium extraction from lean ore brine was considered difficult to realize whether from aspect of the technical breakthrough or economical profit, unbalanced in input and output.
Sunresin has cooperated with Shaanxi Membrane Separation Technology Research Institute Co., Ltd. to overcome this technology and undertake the commissioning of Qinghai lean ore brine 100t/a lithium carbonate project. The EPC project has entered the normal operation stage and has produced high-purity lithium carbonate.
The technology adopts the combination of adsorption separation and membrane separation, could realize high lithium-magnesium ratio (1300:1) lean ore brine to extract lithium, combined with the company's existing impurity removal technology and system equipment technology, could achieve the mass production of lithium carbonate in battery-level high purity,shows obvious economic and environmental advantages.
Our Technology Advantages
- High-performance lithium adsorbent
- Combination with Membrane separation techniques
- Patented continuous ion exchange technology
- Successful EPC project service
High-performance Lithium Adsorbent
SEPLITE® resin for Lithium extraction maintains the basic body performance during lithium adsorption. Compared with similar products, the adsorption capacity is higher and the strength is better. In addition, Sunresin’s continuous ion exchange technology can guarantee the stability of the concentration of lithium ions and the ratio of magnesium lithium in the desorption solution, and further improve the product performance.
Our Product List
Latest News
01
2025 07
Sunresin Bioprocess Materials Achieve DMF Registration, Supporting Global Biopharma Compliance
Sunresin has obtained 10 Drug Master File (DMF) registrations for its chromatography resins used in antibody, vaccine, and gene therapy production. With 9 more products under review, Sunresin provides robust regulatory support for global pharmaceutical customers and accelerates IND/NDA filing efficiency with FDA and EMA compliance.
05
2025 06
Sunresin Secures Australian Patent for Lithium Adsorbent Innovation
Sunresin New Materials Co., Ltd. is pleased to announce that its invention titled “A Lithium Adsorbent and Its Preparation Method” has been officially granted a patent in Australia.
11
2025 04
SZSE Visits Sunresin – An ETF Constituent Company in the CSI 500 Index
On the morning of March 28, the Shenzhen Stock Exchange (SZSE), along with representatives from Harvest Fund and over 30 other participants, visited Sunresin— a constituent company of the CSI 500 Index — for a special research and engagement activity.